The Drug Discovery Informatics Market is set to experience significant growth over the coming years. According to Straits Research, the market, valued at USD 2.96 billion in 2022, is projected to grow from USD 3.28 billion in 2023 to an impressive USD 7.44 billion by 2031, expanding at a robust compound annual growth rate (CAGR) of 10.8% during the forecast period from 2023 to 2031.
Drug discovery informatics is revolutionizing pharmaceutical and biotechnology industries by enabling faster, more efficient drug discovery processes. Through advanced computational tools and data-driven approaches, drug discovery informatics accelerates the identification and development of promising therapeutic candidates, reducing time-to-market and R&D costs.
For a comprehensive analysis and in-depth insights, get a full PDF sample copy of the report: https://straitsresearch.com/report/drug-discovery-informatics-market/request-sample
Key Drivers of the Drug Discovery Informatics Market
Several factors are fueling the growth of the drug discovery informatics market, including:
Rising R&D Expenditure: Pharmaceutical companies are increasingly investing in research and development to address unmet medical needs and develop innovative therapies.
Technological Advancements: The adoption of artificial intelligence (AI), machine learning (ML), and big data analytics in drug discovery processes is boosting market growth.
Growing Outsourcing Trend: Many organizations are turning to outsourcing informatics services to specialized firms to enhance efficiency and reduce costs.
Increased Demand for Precision Medicine: As personalized medicine gains traction, informatics solutions are crucial for tailoring treatments based on genetic and molecular profiling.
Key Developments in the Drug Discovery Informatics Market
The market is witnessing notable advancements, such as:
Expansion of cloud-based solutions to enhance collaboration and accessibility.
Integration of AI and ML algorithms for predictive modeling and drug target identification.
Strategic partnerships and acquisitions among key players to expand service offerings and market reach.
For a detailed breakdown of market segmentation, visit: https://straitsresearch.com/report/drug-discovery-informatics-market/segmentation
Top Key Players in the Market
Leading companies driving innovation in the drug discovery informatics market include:
PerkinElmer Inc.
Thermo Fisher Scientific Inc.
Certara
Novo Informatics Pvt. Ltd.
Collaborative Drug Discovery Inc.
Jubilant Life Sciences Limited
Selvita
Charles River Laboratories International Inc.
Cambridge Corporation
Albany Molecular Research, Inc.
GVK Biosciences Private Limited
Infosys Ltd.
Accenture
Oracle
Agilent Technologies Inc.
Market Segmentation Analysis
The drug discovery informatics market is segmented into various categories based on workflow, mode, and service. Key segments include:
By Workflow
Drug Discovery Informatics
Identification and Validation Informatics
Assay Development Informatics
Lead Generation Informatics
Development Informatics
Lead Optimization
FHD Preparation
Phase IA Informatics
Phase IB/2 Informatics
By Mode
Outsourced Informatics
In-house Informatics
By Service
Sequence Analysis Platforms
Molecular Modeling
Docking
Clinical Trial Data Management
Others
For inquiries or to request customization of the report before purchasing, visit: https://straitsresearch.com/buy-now/drug-discovery-informatics-market
About Straits Research
Straits Research is a leading provider of actionable market intelligence, offering research, analytics, and advisory services to businesses across industries. The company’s comprehensive reports are designed to provide deep insights and support strategic decision-making.
Contact Us
Straits Research
Email: [email protected]
Address: 825 3rd Avenue, New York, NY, USA, 10022
Phone: +1 646 905 0080 (US), +91 8087085354 (India), +44 203 695 0070 (UK)
